Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain.

Higginson EE, Ramachandran G, Hazen TH, Kania DA, Rasko DA, Pasetti MF, Levine MM, Tennant SM.

mSphere. 2018 Nov 28;3(6). pii: e00474-18. doi: 10.1128/mSphere.00474-18.

2.

Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.

Higginson EE, Ramachandran G, Panda A, Shipley ST, Kriel EH, DeTolla LJ, Lipsky M, Perkins DJ, Salerno-Goncalves R, Sztein MB, Pasetti MF, Levine MM, Tennant SM.

Infect Immun. 2018 Nov 20;86(12). pii: e00440-18. doi: 10.1128/IAI.00440-18. Print 2018 Dec.

PMID:
30249748
3.

Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, Goldblatt D, Liang H, Bachtiar NS, Yang JS, Goel A, Ramasamy V, Pasetti MF, Pollard AJ; anti-Vi IgG working group.

Biologicals. 2018 Nov;56:29-38. doi: 10.1016/j.biologicals.2018.09.001. Epub 2018 Sep 7.

4.

Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.

Hegerle N, Choi M, Sinclair J, Amin MN, Ollivault-Shiflett M, Curtis B, Laufer RS, Shridhar S, Brammer J, Toapanta FR, Holder IA, Pasetti MF, Lees A, Tennant SM, Cross AS, Simon R.

PLoS One. 2018 Sep 6;13(9):e0203143. doi: 10.1371/journal.pone.0203143. eCollection 2018.

5.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.

Chen WH, Neuzil KM, Boyce CR, Pasetti MF, Reymann MK, Martellet L, Hosken N, LaForce FM, Dhere RM, Pisal SS, Chaudhari A, Kulkarni PS, Borrow R, Findlow H, Brown V, McDonough ML, Dally L, Alderson MR.

Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14.

PMID:
30120069
6.

A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.

Ndungo E, Randall A, Hazen TH, Kania DA, Trappl-Kimmons K, Liang X, Barry EM, Kotloff KL, Chakraborty S, Mani S, Rasko DA, Pasetti MF.

mSphere. 2018 Aug 1;3(4). pii: e00260-18. doi: 10.1128/mSphere.00260-18.

7.

Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial.

Kim L, Liebowitz D, Lin K, Kasparek K, Pasetti MF, Garg SJ, Gottlieb K, Trager G, Tucker SN.

JCI Insight. 2018 Jul 12;3(13). pii: 121077. doi: 10.1172/jci.insight.121077. [Epub ahead of print]

8.

WITHDRAWN: Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, Liang H, Bachtiar NS, Yang JS, Goel A, Ramasamy V, Pasetti MF; anti-Vi IgG working group.

Biologicals. 2018 Jun 23. pii: S1045-1056(18)30165-9. doi: 10.1016/j.biologicals.2018.05.007. [Epub ahead of print] No abstract available.

9.

Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay.

Nahm MH, Yu J, Weerts HP, Wenzel H, Tamilselvi CS, Chandrasekaran L, Pasetti MF, Mani S, Kaminski RW.

mSphere. 2018 Jun 13;3(3). pii: e00146-18. doi: 10.1128/mSphere.00146-18. Print 2018 Jun 27.

10.

Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.

Baliban SM, Curtis B, Toema D, Tennant SM, Levine MM, Pasetti MF, Simon R.

PLoS Negl Trop Dis. 2018 May 23;12(5):e0006522. doi: 10.1371/journal.pntd.0006522. eCollection 2018 May.

11.

Acknowledgment of Ad Hoc Reviewers.

Pasetti MF.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00274-17. doi: 10.1128/CVI.00274-17. Print 2017 Dec. No abstract available.

12.

Enterotoxigenic Escherichia coli is phagocytosed by macrophages underlying villus-like intestinal epithelial cells: modeling ex vivo innate immune defenses of the human gut.

Noel G, Doucet M, Nataro JP, Kaper JB, Zachos NC, Pasetti MF.

Gut Microbes. 2017 Oct 31:0. doi: 10.1080/19490976.2017.1398871. [Epub ahead of print]

13.

The Legacy of CVI.

Pasetti MF, Douglas SD, Plaeger SF.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00276-17. doi: 10.1128/CVI.00276-17. Print 2017 Dec.

14.

A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x108 colony forming units [cfu] standard-dose versus a ≥2x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccine, with Shanchol inactivated oral vaccine as an open label immunologic comparator.

Sow SO, Tapia MD, Chen WH, Haidara FC, Kotloff KL, Pasetti MF, Blackwelder WC, Traoré A, Tamboura B, Doumbia M, Diallo F, Coulibaly F, Onwuchekwa U, Kodio M, Tennant SM, Reymann M, Lam DF, Gurwith M, Lock M, Yonker T, Smith J, Simon JK, Levine MM.

Clin Vaccine Immunol. 2017 Oct 11. pii: CVI.00265-17. doi: 10.1128/CVI.00265-17. [Epub ahead of print]

15.

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB; DMID 08-0006 Tularemia Vaccine Study Group.

Vaccine. 2017 Aug 24;35(36):4730-4737. doi: 10.1016/j.vaccine.2017.07.024. Epub 2017 Jul 24.

16.

Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.

Sears KT, Tennant SM, Reymann MK, Simon R, Konstantopoulos N, Blackwelder WC, Barry EM, Pasetti MF.

Clin Vaccine Immunol. 2017 Aug 4;24(8). pii: e00186-16. doi: 10.1128/CVI.00186-16. Print 2017 Aug.

17.

Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity.

Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, Devaraj S, Tessier ME, von Rosenvinge EC, Kelly CP, Pasetti MF, Feng H.

Clin Vaccine Immunol. 2017 Aug 4;24(8). pii: e00037-17. doi: 10.1128/CVI.00037-17. Print 2017 Aug.

18.

Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.

McArthur MA, Maciel M Jr, Pasetti MF.

Vaccine. 2017 Dec 14;35(49 Pt A):6803-6806. doi: 10.1016/j.vaccine.2017.05.034. Epub 2017 May 27.

19.

Erratum: A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions.

Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, Zachos NC.

Sci Rep. 2017 May 3;7:46790. doi: 10.1038/srep46790. No abstract available.

20.

A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions.

Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, Zachos NC.

Sci Rep. 2017 Mar 27;7:45270. doi: 10.1038/srep45270. Erratum in: Sci Rep. 2017 May 03;7:46790.

21.

Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.

Shimanovich AA, Buskirk AD, Heine SJ, Blackwelder WC, Wahid R, Kotloff KL, Pasetti MF.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00412-16. doi: 10.1128/CVI.00412-16. Print 2017 Feb.

22.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JH, Shenk T.

mSystems. 2016 Jul 11;1(4). pii: e00088-16. eCollection 2016 Jul-Aug.

23.

Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity.

Galen JE, Buskirk AD, Tennant SM, Pasetti MF.

EcoSal Plus. 2016 Nov;7(1). doi: 10.1128/ecosalplus.ESP-0010-2016. Review.

24.

Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.

Chen WH, Pasetti MF, Adhikari RP, Baughman H, Douglas R, El-Khorazaty J, Greenberg N, Holtsberg FW, Liao GC, Reymann MK, Wang X, Warfield KL, Aman MJ.

Clin Vaccine Immunol. 2016 Dec 5;23(12):918-925. Print 2016 Dec.

25.

Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis.

Koshiol J, Wozniak A, Cook P, Adaniel C, Acevedo J, Azócar L, Hsing AW, Roa JC, Pasetti MF, Miquel JF, Levine MM, Ferreccio C; Gallbladder Cancer Chile Working Group.

Cancer Med. 2016 Nov;5(11):3310-3235. doi: 10.1002/cam4.915. Epub 2016 Oct 11. Review.

26.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

Microbiol Mol Biol Rev. 2016 Jul 13;80(3):i-ii. doi: 10.1128/MMBR.00042-16. Print 2016 Sep. No abstract available.

27.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

mSphere. 2016 Jul 11;1(4). pii: e00184-16. doi: 10.1128/mSphere.00184-16. eCollection 2016 Jul-Aug.

28.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

J Clin Microbiol. 2016 Sep;54(9):2216-7. doi: 10.1128/JCM.01418-16. Epub 2016 Jul 11. No abstract available.

29.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

MBio. 2016 Jul 11;7(4). pii: e01150-16. doi: 10.1128/mBio.01150-16. No abstract available.

30.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

Clin Microbiol Rev. 2016 Oct;29(4):i-ii. doi: 10.1128/CMR.00070-16. No abstract available.

31.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

Appl Environ Microbiol. 2016 Aug 30;82(18):5479-80. doi: 10.1128/AEM.01986-16. Print 2016 Sep 15. No abstract available.

32.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5109-10. doi: 10.1128/AAC.01423-16. Print 2016 Sep. No abstract available.

33.

ASM Journals Eliminate Impact Factor Information from Journal Websites.

Casadevall A, Bertuzzi S, Buchmeier MJ, Davis RJ, Drake H, Fang FC, Gilbert J, Goldman BM, Imperiale MJ, Matsumura P, McAdam AJ, Pasetti MF, Sandri-Goldin RM, Silhavy T, Rice L, Young JA, Shenk T.

Infect Immun. 2016 Aug 19;84(9):2407-8. doi: 10.1128/IAI.00564-16. Print 2016 Sep. No abstract available.

34.

Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.

Tapia MD, Sow SO, Tamboura B, Tégueté I, Pasetti MF, Kodio M, Onwuchekwa U, Tennant SM, Blackwelder WC, Coulibaly F, Traoré A, Keita AM, Haidara FC, Diallo F, Doumbia M, Sanogo D, DeMatt E, Schluterman NH, Buchwald A, Kotloff KL, Chen WH, Orenstein EW, Orenstein LAV, Villanueva J, Bresee J, Treanor J, Levine MM.

Lancet Infect Dis. 2016 Sep;16(9):1026-1035. doi: 10.1016/S1473-3099(16)30054-8. Epub 2016 May 31.

35.

Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.

Levine MM, Pasetti MF.

Clin Vaccine Immunol. 2016 Jul 5;23(7):532-4. doi: 10.1128/CVI.00259-16. Print 2016 Jul.

36.

Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

DeLaine BC, Wu T, Grassel CL, Shimanovich A, Pasetti MF, Levine MM, Barry EM.

Pathog Dis. 2016 Jul;74(5). pii: ftw034. doi: 10.1093/femspd/ftw034. Epub 2016 Apr 21.

37.

Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.

Ramachandran G, Boyd MA, MacSwords J, Higginson EE, Simon R, Galen JE, Pasetti MF, Levine MM, Tennant SM.

Clin Vaccine Immunol. 2016 Jun 6;23(6):520-523. doi: 10.1128/CVI.00106-16. Print 2016 Jun.

38.

Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.

Chen WH, Cohen MB, Kirkpatrick BD, Brady RC, Galloway D, Gurwith M, Hall RH, Kessler RA, Lock M, Haney D, Lyon CE, Pasetti MF, Simon JK, Szabo F, Tennant S, Levine MM.

Clin Infect Dis. 2016 Jun 1;62(11):1329-1335. doi: 10.1093/cid/ciw145. Epub 2016 Mar 21.

39.

Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.

Ramachandran G, Tennant SM, Boyd MA, Wang JY, Tulapurkar ME, Pasetti MF, Levine MM, Simon R.

PLoS One. 2016 Mar 21;11(3):e0151875. doi: 10.1371/journal.pone.0151875. eCollection 2016.

40.

Springtime for CVI.

Pasetti MF.

Clin Vaccine Immunol. 2016 Apr 4;23(4):247. doi: 10.1128/CVI.00102-16. Print 2016 Apr. No abstract available.

41.

Highlights of the 8th International Conference on Vaccines for Enteric Diseases: the Scottish Encounter To Defeat Diarrheal Diseases.

Tennant SM, Steele AD, Pasetti MF.

Clin Vaccine Immunol. 2016 Apr 4;23(4):272-81. doi: 10.1128/CVI.00082-16. Print 2016 Apr.

42.

Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.

Travassos MA, Beyene B, Adam Z, Campbell JD, Mulholland N, Diarra SS, Kassa T, Oot L, Sequeira J, Reymann M, Blackwelder WC, Wu Y, Ruslanova I, Goswami J, Sow SO, Pasetti MF, Steinglass R, Kebede A, Levine MM.

PLoS One. 2016 Mar 2;11(3):e0149970. doi: 10.1371/journal.pone.0149970. eCollection 2016.

43.

Simple method for purification of enterotoxigenic Escherichia coli fimbriae.

Curtis B, Grassel C, Laufer RS, Sears KT, Pasetti MF, Barry EM, Simon R.

Protein Expr Purif. 2016 Mar;119:130-5. doi: 10.1016/j.pep.2015.11.007. Epub 2015 Nov 12.

44.

Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.

Tennant SM, Schmidlein P, Simon R, Pasetti MF, Galen JE, Levine MM.

Infect Immun. 2015 Dec;83(12):4504-12. doi: 10.1128/IAI.00924-15. Epub 2015 Sep 8.

45.

Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey.

Travassos MA, Beyene B, Adam Z, Campbell JD, Mulholland N, Diarra SS, Kassa T, Oot L, Sequeira J, Reymann M, Blackwelder WC, Pasetti MF, Sow SO, Steinglass R, Kebede A, Levine MM.

Am J Trop Med Hyg. 2015 Aug;93(2):416-24. doi: 10.4269/ajtmh.15-0198. Epub 2015 Jun 8.

46.

Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.

Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM.

Clin Infect Dis. 2015 Aug 1;61(3):393-402. doi: 10.1093/cid/civ295. Epub 2015 Apr 13.

PMID:
25870324
47.

Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.

Heine SJ, Franco-Mahecha OL, Chen X, Choudhari S, Blackwelder WC, van Roosmalen ML, Leenhouts K, Picking WL, Pasetti MF.

Immunol Cell Biol. 2015 Aug;93(7):641-52. doi: 10.1038/icb.2015.24. Epub 2015 Mar 17.

48.

A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Galen JE, Wang JY, Carrasco JA, Lloyd SA, Mellado-Sanchez G, Diaz-McNair J, Franco O, Buskirk AD, Nataro JP, Pasetti MF.

Infect Immun. 2015 Jan;83(1):161-72. doi: 10.1128/IAI.02443-14. Epub 2014 Oct 20.

49.

Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.

Toapanta FR, Simon JK, Barry EM, Pasetti MF, Levine MM, Kotloff KL, Sztein MB.

Front Immunol. 2014 Aug 20;5:374. doi: 10.3389/fimmu.2014.00374. eCollection 2014.

50.

A scalable method for biochemical purification of Salmonella flagellin.

Simon R, Curtis B, Deumic V, Nicki J, Tennant SM, Pasetti MF, Lees A, Wills PW, Chacon M, Levine MM.

Protein Expr Purif. 2014 Oct;102:1-7. doi: 10.1016/j.pep.2014.07.005. Epub 2014 Jul 19.

Supplemental Content

Loading ...
Support Center